The BioPharm America 2010/MassBio Investors Forum will be held on September 15-17 at the Copley Marriott in Boston, MA.  NYBA members receive a $200 discount at registration! 

 

Meet new potential partners, catch up on current relationships, and see company presentations featuring the best and brightest technologies.

Join companies like:

  

  A.  Menarini - MDRNA - Adimab - Merck & Co., Inc.  - Algol Pharma - Mersana Therapeutics - Amgen - Millennium/Takeda - Anchor Therapeutics - MPM  Capital - Astellas - Novacta Biosystems - Bayer Schering Pharma  - Novartis - Biogen Idec - Novartis Option Fund - BioSante Pharmaceuticals  - Nycomed - Cephalon  - Ono  Pharmaceuticals - Cerulean Pharma - On-Q-ity  - Charles  River - Oxford Bioscience  Partners - Constellation Pharmaceuticals - Pacific Biometrics - Cubist Pharmaceuticals - Paratek - Elan Drug Technologies  - Pervasis Therapeutics - Eli  Lilly and Company - Peter J. Solomon Company - EMD  Serono  Pfizer - Endo Pharmaceuticals  Polaris Venture Partners - EnVivo Pharmaceuticals - Puretech Ventures - Fate Therapeutics - Recordati Flagship Ventures  - Revotar Biopharmaceuticals - Genta Incorporated  Roche/Genentech - Genzyme  Sanofi-aventis - GSK  HealthCare Ventures - Santhera Pharmaceuticals - Idera Pharmaceuticals  Satori Pharmaceuticals - Index Ventures  Shire - Ironwood Pharmaceuticals - Supernus Pharmaceuticals - Japan Tobacco  Pharma - Taligen Therapeutics - Johnson & Johnson  - Tempero Pharmaceuticals - Leukemia & Lymphoma Society - Tengion Logical Therapeutics  - Third Rock Ventures - MacroGenics  - UCB  Pharma

 

In partnership with BioPharm America, the 2010 MassBio Investors Forum will convene companies from across the globe to partner and invest in Massachusetts’s most innovative companies.

 

MassBio and EBD Group will make this combined event North America’s premiere partnering conference -- creating a unique, high powered business exchange uniting international and world class life sciences companies at one location for three days.

 

Robert Langer will provide the opening keynote remarks for this event and our panels will tackle the most critical issues facing the industry today, including:

• Building a Sustainable Business in Biotech  

• Financing for Phase I/II Assets  

• Bridging the Valley of Death: Who will Finance Innovation?   

• Strategic Investments and Alliances: Is Corporate Venture Replacing  Traditional Venture Capital?
• (Global) Collaborative Business Models 

• Serial Entrepreneurs: What Makes Them Do It Again, and Again, and  Again?  

• Driving Personalized Medicine: The New Business Model Among Rx, Dx,  Medtech and Payors 

 

BioPharm America 2010/MassBio Investors Forum promises to be a must-attend event where life science leaders engage in discussion and collaboration to take our industry through the next decade and beyond.

 

For more information and to register, visit http://www.ebdgroup.com/bpa